Table 1. Patient characteristics.

No.	Age (years)	Sex	WHO classification	Masaoka stage	Other autoimmune disease	Preoperative therapy	Thymectomy	Macroscopically Resection	Postoperative therapy	Recurrence of thymoma after SR (months)	Onset of PRCA based on SR (months)	Treatment for PRCA	Outcome of PRCA	Complications of CSP	Survival after onset of PRCA (months)	Outcome	Cause of death
1	46	F	B2	III	None	High-dose steroids	Standard	Complete	Radiation	15	+3	CSP, PSL	Remission	Pneumonia	147	Dead	Pneumonia
2	71	M	A	II	None	None	Standard	Complete	None	None	−60	Transfusion	TD	–	70	Dead	Cardiac Failure
3	45	F	B3	IVa	None	High-dose steroids	Extended	Incomplete	Radiation	–	+53	CSP	Remission	Pneumonia	22	Dead	Pneumonia
4	57	M	B2	III	MG, ITP	None	Extended	Complete	None	19	+101	CSP, PSL	TD	Pneumonia	39	Alive	–
5	55	F	B3	IVb	None	None	Extended	Complete	Radiation	18	+75	CSP	TD	Pneumonia, RI	29	Dead	Pneumonia
6	51	M	B2	IVa	None	Cytotoxic agents	Extended	Incomplete	Radiation	–	+1	CSP	TD	Pneumonia	103	Dead	Pneumonia
7	80	M	B2	III	None	High-dose steroids	Standard	Complete	None	38	−1	Transfusion	TD	–	87	Alive	–
8	64	M	B2	IVb	None	High-dose steroids	Standard	Incomplete	Radiation	–	+60	CSP	Remission	Pneumonia	13	Alive	–

M, male; F, female; MG, myasthenia gravis; ITP, idiopathic thrombocytopenic purpura; SR, surgical resection; PRCA, pure red cell aplasia; CSP, cyclosporine; PSL, prednisolone; TD, transfusion-dependent; RI, renal insufficiency.